Why the study?
Does clinical audit reduce the time taken to administer thrombolysis and aspirin in patients with acute myocardial infarction?
Does clinical audit reduce the time taken to administer thrombolysis and aspirin in patients with acute myocardial infarction?
Clinical audit and guideline implementation significantly reduce the time to administer critical therapies like thrombolysis and aspirin in acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports clinical audit to shorten AMI treatment times; leaves open need for randomized confirmation of durability.
We assessed whether audit might reduce the time taken to give thrombolysis and aspirin in patients with acute myocardial infarction (N = 116). A retrospective analysis was performed of the sources of delay in giving the drugs (N-60) and the data were presented to clinical staff accompanied by guidelines aimed at eliminating delays. A prospective survey was undertaken (N = 56) after these interventions. Audit resulted in an overall 31% reduction (P = 0.013) in the time to administer thrombolysis (median 55 minutes [range 21-148] v 38 [15-155]): there was a 57% fall (P < 0.0001) in the time to record an electrocardiogram (14 minutes [4-34] v 6 [1-19]) and a 33% decrease (P = 0.047) in the time taken to begin thrombolysis in the coronary care unit (15 minutes [0-110) v 10 [5-70]). The time taken to give aspirin was also reduced (P = 0.001) from 58 minutes (15-400) to 15 (3-235). The time taken to administer thrombolysis and aspirin to patients admitted with acute myocardial infarction can be reduced by audit.
No takes yet. Share an insight, caveat, or question.
Currie et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: